Doing now what patients need next!
Read our community guidelines: https://go.roche.com/CG
Location: United States, Massachusetts, Lexington
Employees: 10001+
Total raised: $58M
Founded date: 1896
Investors 4
| Date | Name | Website |
| - | Forbion | forbion.co... |
| - | Sofinnova ... | sofinnova.... |
| - | Lightstone... | lightstone... |
| - | Easton Cap... | eastoncapi... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 15.10.2012 | Series D | $24.5M | - |
| 08.03.2012 | Series D | $21.5M | - |
| 16.03.2010 | Series C | $12M | Forbion |
Mentions in press and media 21
| Date | Title | Description | Source |
| 18.01.2024 | VectorY appoints Khurem Farooq to Board of Directors | · CEO and Co-Founder of Aiolos Bio and previous CEO of Gyroscope Khurem Farooq joins as independent ... | forbion.co... |
| 27.06.2023 | AMG Announces Partnership with Forbion | • AMG to invest in Forbion, a leading pan-European life sciences venture capital and growth equity f... | forbion.co... |
| 19.04.2023 | Forbion raises €1.35 billion across two funds | • Forbion’s largest fundraising to date • €750 million raised in the final close of the Forbion Ven... | forbion.co... |
| 04.11.2021 | Roche Holding AG announces an Equity Buyback for 53,300,000 ... | Roche Holding AG (SWX:ROG) announces a share repurchase program. Under the program, the company will... | marketscre... |
| 15.11.2019 | Roche to Acquire Promedior | Promedior, Inc., today announced that it has entered into a definitive merger agreement for Roche (S... | citybizlis... |
| 15.11.2019 | Roche to Acquire Promedior | Promedior, Inc., today announced that it has entered into a definitive merger agreement for Roche (S... | archive.ci... |
| 15.10.2012 | Promedior Expands Series D Round to $24.5M | MALVERN, PA, Clinical stage biotechnology company developing novel biologic therapeutics for the t... | vcnewsdail... |
| 15.10.2012 | Biotech startup can expand scope of lead fibrotic disease tr... | The company is also accelerating the development of its drug candidate for fibrovascular retinal dis... | medcitynew... |
| 15.10.2012 | Promedior Adds $3M in Series D Financing | Promedior, Inc., a Malvern, PA-based clinical stage biotechnology company developing novel biologic ... | finsmes.co... |
| 13.03.2012 | Promedior Secures $21.5M Series D | MALVERN, PA, Clinical stage biotechnology company developing novel biologic therapeutics for the t... | vcnewsdail... |
Show more